DAR ES SALAAM: TANZANIA Biotech Production Limited (TBPL) has registered a revenue increase of almost 8.0 per cent after selling anti-mosquito agents for the year ending June.
The anti-mosquito agents are part of biolarvicides that are produced by the biotech firm based in Kibaha Coast region.
The bestseller product is Thurisave 24.
The firm told the ‘Daily News’ yesterday that they sold 58,477 litres of biolarvicides worth 771.9m/- in the 2023/2024 up from 735.06m/- registered in the previous year.
The TBPL Business Manager, Mr Samwel Mziray, said that most of the products were sold locally while 8,000 litres were exported to Kenya and 500 litres to Mozambique.
“We are eyeing to exports more to the East African Community (EAC) and Southern African Development Community (SADC) markets,” Mr Mziray said.
For the locally market, the firm said they expect to secure sales in sugar factories such as Mtibwa and Kilombero which are at the major mosquito breeding grounds.
ALSO READ: Kagera hails govt measures to rescue TANICA
“Apart from sugar factories we have visited larger mining companies in Geita and Mara as part of the education awareness campaign,” Mr Mziray said.
Additionally, TBPL visited Zanzibar to provide education on insecticide and raise awareness of the use of biolarvicides.
To boosts sales the firm appointed agents in five regions Tanga, Dar es Salaam, Morogoro, Shinyanga, and Mbeya.
The factory under the National Development Corporation (NDC) aims to wipe out mosquito vector borne diseases such as malaria, dengue and zika.
The NDC Director General, Dr Nicholas Shombe said that the TBPL could be the source of foreign exchange since it has the potential of exporting its products.
“The products have already been able to penetrate the foreign markets and proved to be of high quality to illuminate the larvae of all types of mosquitoes without affecting the environment or other organisms,” said Dr Shombe.
